Creative Biolabs has announced an integrated service that combines custom oligosaccharide synthesis with advanced glycan characterization, aiming to support drug discovery and biomedical research. The service addresses the structural complexity of oligosaccharides, which often complicates synthesis, purification, and analysis in glycan-based therapeutics, vaccines, and biomarker studies.
Oligosaccharides play critical roles in cell signaling, immune regulation, pathogen-host interactions, and disease progression, making them valuable tools for therapeutic, vaccine, and diagnostic research. However, their intricate structures pose significant challenges. To address these, Creative Biolabs leverages chemical, enzymatic, and chemoenzymatic synthesis technologies alongside comprehensive analytical platforms such as mass spectrometry (MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR).
“The structural complexity of oligosaccharides continues to present significant challenges for researchers developing next-generation therapeutics,” said a scientist from Creative Biolabs. “By integrating custom synthesis with comprehensive analytical characterization, we help researchers obtain structurally validated glycans that support reliable downstream studies and accelerate scientific discovery.”
Researchers utilizing Creative Biolabs’ glycan services have highlighted both the quality of the synthesized products and the comprehensive technical support provided throughout their projects. In one recent project, researchers required a complex glycan structure not readily available through standard commercial sources. Integrated synthesis and analytical characterization helped support downstream structural confirmation.
The company’s portfolio includes custom synthesis of high-purity oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized carbohydrate derivatives. Advanced characterization services determine glycan structures, linkage patterns, sequences, and purity. Application-oriented carbohydrate design supports structural biology, glycoprotein research, biomarker discovery, immunology, targeted drug delivery, and therapeutic development.
By combining custom carbohydrate synthesis with rigorous analytical characterization under one integrated platform, Creative Biolabs helps researchers reduce technical risks, improve experimental reproducibility, support more efficient project progression, and accelerate scientific innovation. Researchers can explore customized oligosaccharide synthesis and glycan characterization options through Creative Biolabs’ glycobiology platform at https://www.creative-biolabs.com/glycoprotein/.
